198e (Confidence: 8)
~ (Confidence: 0)
87/18/2024 (Confidence: 15)
14,14 (Confidence: 77)
8054171226 (Confidence: 49)
bi (Confidence: 17)
aaa (Confidence: 15)
#2008 (Confidence: 71)
P. (Confidence: 24)
007/002 (Confidence: 76)
fom (Confidence: 45)
lily (Confidence: 30)
BAY (Confidence: 24)
f (Confidence: 89)
10555 (Confidence: 88)
JANE (Confidence: 88)
ST, (Confidence: 85)
MAPLE (Confidence: 92)
L6A (Confidence: 67)
311 (Confidence: 84)
UW (Confidence: 32)
2s (Confidence: 36)
ana) (Confidence: 32)
Friciay, (Confidence: 57)
July (Confidence: 96)
19, (Confidence: 95)
2024 (Confidence: 95)
SILDOM (Confidence: 87)
DRUG (Confidence: 96)
MART (Confidence: 96)
i (Confidence: 65)
ee (Confidence: 16)
Tel: (Confidence: 85)
(905) (Confidence: 21)
417-1 (Confidence: 21)
288 (Confidence: 73)
Fax: (Confidence: 90)
(905) (Confidence: 88)
417-1226 (Confidence: 81)
SILDOM (Confidence: 92)
DRUG (Confidence: 96)
MART (Confidence: 96)
_____ (Confidence: 11)
Patient (Confidence: 43)
info (Confidence: 78)
Stephanie (Confidence: 93)
DXATESTING (Confidence: 91)
#18-700 (Confidence: 90)
SUMMERIDGE (Confidence: 92)
MARKHAM (Confidence: 96)
Tel; (Confidence: 96)
4167074704 (Confidence: 75)
DOB: (Confidence: 86)
Mar (Confidence: 92)
21,'198¢ (Confidence: 80)
ace: (Confidence: 72)
35 (Confidence: 96)
Form (Confidence: 84)
EnteriUCode (Confidence: 0)
Doetor's (Confidence: 59)
SI (Confidence: 3)
OZEMPIC (Confidence: 91)
PREF (Confidence: 96)
PEN (Confidence: 76)
INJ (Confidence: 76)
(SEMAGLUTIDE) (Confidence: 71)
—0.48MG/ML (Confidence: 2)
INd (Confidence: 49)
Lh (Confidence: 60)
g (Confidence: 81)
: (Confidence: 38)
ad! (Confidence: 36)
TS (Confidence: 26)
- (Confidence: 79)
oy: (Confidence: 47)
2 (Confidence: 47)
pens (Confidence: 53)
Refits: (Confidence: 51)
—F—irections:_ (Confidence: 31)
stuck (Confidence: 45)
o. (Confidence: 0)
255 (Confidence: 30)
WEY (Confidence: 66)
MG (Confidence: 49)
> (Confidence: 48)
Thin (Confidence: 46)
5 (Confidence: 42)
5 (Confidence: 43)
wht (Confidence: 18)
Ontario (Confidence: 91)
Drug (Confidence: 91)
Bencfit (Confidence: 74)
Will (Confidence: 90)
Not (Confidence: 76)
Pay (Confidence: 95)
For (Confidence: 86)
This (Confidence: 84)
Ding (Confidence: 30)
Unless (Confidence: 54)
Authorized (Confidence: 86)
i8y (Confidence: 35)
The (Confidence: 78)
Doctor, (Confidence: 96)
ease (Confidence: 51)
Fill (Confidence: 94)
& (Confidence: 67)
Sign (Confidence: 74)
The (Confidence: 96)
Above (Confidence: 77)
Inftsnistion. (Confidence: 14)
<7, (Confidence: 80)
For (Confidence: 96)
the (Confidence: 93)
treatment (Confidence: 0)
of (Confidence: 95)
adult (Confidence: 94)
patents (Confidence: 21)
with (Confidence: 91)
iype (Confidence: 82)
2 (Confidence: 96)
diabetes (Confidence: 87)
When (Confidence: 94)
adequate (Confidence: 90)
glycemic (Confidence: 41)
contol (Confidence: 42)
Is (Confidence: 68)
nat (Confidence: 83)
achieved (Confidence: 64)
on (Confidence: 95)
the (Confidence: 95)
maximum (Confidence: 95)
tolerated (Confidence: 91)
dose (Confidence: 81)
of (Confidence: 96)
metformin (Confidence: 82)
or (Confidence: 95)
where (Confidence: 92)
metfonnin (Confidence: 25)
is (Confidence: 80)
Contraindicated (Confidence: 72)
or (Confidence: 80)
inappropriate. (Confidence: 41)
Semeglutide (Confidence: 24)
is (Confidence: 96)
not (Confidence: 93)
tunded (Confidence: 83)
in (Confidence: 96)
combination (Confidence: 44)
with (Confidence: 95)
another (Confidence: 93)
glucagon-iike (Confidence: 56)
peptide-1 (Confidence: 68)
receptor (Confidence: 95)
~~ (Confidence: 61)
agonist (Confidence: 92)
(CLP-1 (Confidence: 30)
RA) (Confidence: 82)
or (Confidence: 93)
dipeptidy! (Confidence: 45)
peptidase-4 (Confidence: 69)
(DPP-4) (Confidence: 64)
inhibitar (Confidence: 68)
: (Confidence: 81)
Injectable (Confidence: 15)
somaglutice (Confidence: 0)
ws (Confidence: 22)
not (Confidence: 95)
funded (Confidence: 95)
in (Confidence: 96)
combination (Confidence: 89)
with (Confidence: 95)
oral (Confidence: 74)
semagiutide. (Confidence: 68)
Coverage (Confidence: 88)
is (Confidence: 80)
only (Confidence: 81)
provitied (Confidence: 88)
for (Confidence: 95)
one (Confidence: 95)
dosage (Confidence: 86)
former, (Confidence: 43)
Reimbursed (Confidence: 84)
dose: (Confidence: 95)
As (Confidence: 95)
per (Confidence: 95)
the (Confidence: 96)
product (Confidence: 92)
monograph (Confidence: 68)
LU (Confidence: 90)
Authorization (Confidence: 50)
Pariod: (Confidence: 61)
Indefinite (Confidence: 92)
279 (Confidence: 95)
From (Confidence: 93)
Janyery (Confidence: 58)
31, (Confidence: 92)
2024 (Confidence: 91)
to (Confidence: 95)
April (Confidence: 82)
30, (Confidence: 96)
2024 (Confidence: 94)
re (Confidence: 17)
The (Confidence: 96)
LU (Confidence: 72)
criteria (Confidence: 39)
for (Confidence: 89)
Ozernpic (Confidence: 84)
are (Confidence: 95)
consistent (Confidence: 96)
with (Confidence: 92)
the (Confidence: 93)
pravious (Confidence: 90)
therapeutic (Confidence: 90)
notes (Confidence: 45)
and (Confidence: 96)
with (Confidence: 92)
the (Confidence: 92)
Health (Confidence: 93)
Caneda~approved (Confidence: 72)
indication (Confidence: 61)
of (Confidence: 96)
type (Confidence: 95)
2 (Confidence: 94)
diabetes. (Confidence: 93)
Ozempic (Confidence: 87)
is (Confidence: 96)
not (Confidence: 89)
funded (Confidence: 81)
for (Confidence: 93)
ODB (Confidence: 90)
program (Confidence: 95)
recipients (Confidence: 81)
who (Confidence: 96)
do (Confidence: 93)
not (Confidence: 93)
meet (Confidence: 96)
the (Confidence: 96)
LU (Confidence: 79)
criteria (Confidence: 86)
on (Confidence: 94)
the (Confidence: 96)
Formulary. (Confidence: 31)
Cleims (Confidence: 82)
{ (Confidence: 90)
Pan (Confidence: 55)
for (Confidence: 85)
payment (Confidence: 93)
for (Confidence: 94)
dispensing (Confidence: 93)
Ozempic (Confidence: 74)
for (Confidence: 92)
OB (Confidence: 38)
program (Confidence: 91)
ractpients (Confidence: 72)
who (Confidence: 94)
do (Confidence: 76)
not (Confidence: 76)
meet (Confidence: 74)
the (Confidence: 93)
LU (Confidence: 95)
requirement (Confidence: 94)
will (Confidence: 88)
be (Confidence: 95)
subject (Confidence: 79)
to (Confidence: 82)
recovery. (Confidence: 82)
Claims (Confidence: 65)
for (Confidence: 96)
payment (Confidence: 91)
for (Confidence: 93)
Ozempic (Confidence: 82)
must (Confidence: 96)
be (Confidence: 96)
: (Confidence: 0)
5 (Confidence: 52)
supported (Confidence: 67)
by (Confidence: 91)
@ (Confidence: 74)
prescription (Confidence: 76)
that (Confidence: 92)
includes (Confidence: 92)
the (Confidence: 96)
applicable (Confidence: 86)
Reason (Confidence: 95)
for (Confidence: 96)
Use (Confidence: 96)
(RFU) (Confidence: 96)
code, (Confidence: 92)
PI (Confidence: 57)
jibe (Confidence: 13)
ZB, (Confidence: 10)
88 (Confidence: 50)
described (Confidence: 91)
further (Confidence: 94)
in (Confidence: 89)
the (Confidence: 92)
Ontario (Confidence: 92)
Drug (Confidence: 92)
Programs (Confidence: 94)
Reference (Confidence: 45)
Marval. (Confidence: 40)
wet (Confidence: 20)
4 (Confidence: 69)
Batween (Confidence: 89)
January (Confidence: 91)
31, (Confidence: 87)
2024 (Confidence: 93)
fo (Confidence: 61)
April (Confidence: 94)
30, (Confidence: 95)
2024, (Confidence: 96)
pharmacists (Confidence: 72)
can (Confidence: 96)
use (Confidence: 96)
LU (Confidence: 70)
Code (Confidence: 94)
279 (Confidence: 95)
to (Confidence: 96)
submit (Confidence: 96)
S (Confidence: 0)
a (Confidence: 51)
claim (Confidence: 58)
for (Confidence: 93)
Ozampic (Confidence: 65)
(DiNs (Confidence: 86)
02471469, (Confidence: 93)
02471477, (Confidence: 90)
02540258) (Confidence: 62)
if (Confidence: 87)
they (Confidence: 95)
are (Confidence: 93)
unable (Confidence: 93)
to (Confidence: 96)
contact (Confidence: 92)
/ (Confidence: 90)
| (Confidence: 75)
l. (Confidence: 13)
8 (Confidence: 31)
patient's (Confidence: 88)
prescriber (Confidence: 4)
fo (Confidence: 91)
obtain (Confidence: 52)
a (Confidence: 68)
new (Confidence: 95)
prescription (Confidence: 88)
with (Confidence: 88)
the (Confidence: 96)
LU (Confidence: 79)
criteria. (Confidence: 88)
This (Confidence: 94)
wii! (Confidence: 53)
U (Confidence: 82)
> (Confidence: 79)
ensure (Confidence: 93)
patients (Confidence: 94)
do (Confidence: 84)
not (Confidence: 89)
go (Confidence: 96)
without (Confidence: 96)
their (Confidence: 83)
drug (Confidence: 92)
until (Confidence: 92)
they (Confidence: 92)
ave (Confidence: 91)
able (Confidence: 83)
to (Confidence: 90)
contact (Confidence: 93)
their (Confidence: 93)
prescriber (Confidence: 66)
- (Confidence: 75)
The (Confidence: 96)
rules (Confidence: 75)
regarding (Confidence: 96)
the (Confidence: 96)
use (Confidence: 91)
of (Confidence: 94)
LU (Confidence: 94)
code (Confidence: 95)
279 (Confidence: 91)
are (Confidence: 71)
set (Confidence: 94)
out (Confidence: 89)
in (Confidence: 93)
the (Confidence: 95)
Ontario (Confidence: 93)
Drug (Confidence: 96)
Programs (Confidence: 85)
Tanks (Confidence: 46)
Reference (Confidence: 95)
Manual. (Confidence: 90)
Please (Confidence: 71)
refer (Confidence: 57)
to (Confidence: 91)
the (Confidence: 96)
Executive (Confidence: 90)
Officer (Confidence: 95)
Notice (Confidence: 96)
for (Confidence: 96)
more (Confidence: 96)
information. (Confidence: 35)
- (Confidence: 27)
‘ (Confidence: 0)
RFU (Confidence: 65)
Code (Confidence: 96)
279 (Confidence: 96)
may (Confidence: 96)
be (Confidence: 96)
used (Confidence: 53)
for (Confidence: 96)
up (Confidence: 96)
to (Confidence: 81)
three (Confidence: 90)
months (Confidence: 92)
undil (Confidence: 34)
8 (Confidence: 32)
new (Confidence: 95)
LU (Confidence: 74)
prescviption (Confidence: 54)
Is (Confidence: 65)
' (Confidence: 0)
The (Confidence: 92)
arspensing (Confidence: 26)
pharmacist (Confidence: 95)
cannot (Confidence: 93)
use (Confidence: 93)
the (Confidence: 96)
LU (Confidence: 96)
intervention (Confidence: 93)
code (Confidence: 94)
with (Confidence: 93)
REU (Confidence: 87)
Code (Confidence: 95)
279. (Confidence: 90)
This (Confidence: 96)
RFU (Confidence: 94)
Code (Confidence: 87)
Is (Confidence: 43)
only (Confidence: 55)
vaidd (Confidence: 28)
for (Confidence: 95)
claims (Confidence: 94)
submissions (Confidence: 84)
and (Confidence: 95)
is (Confidence: 78)
not (Confidence: 78)
to (Confidence: 90)
be (Confidence: 94)
used (Confidence: 96)
by (Confidence: 93)
presoribers (Confidence: 40)
on (Confidence: 62)
LU (Confidence: 93)
prescriptions (Confidence: 89)
if (Confidence: 85)
the (Confidence: 92)
REU (Confidence: 88)
code (Confidence: 95)
has (Confidence: 91)
been (Confidence: 95)
discontinued: (Confidence: 91)
RFU (Confidence: 94)
Cade (Confidence: 94)
279 (Confidence: 94)
may (Confidence: 96)
be (Confidence: 96)
used (Confidence: 96)
‘ (Confidence: 42)
Page (Confidence: 89)
| (Confidence: 95)
of (Confidence: 76)
2 (Confidence: 76)
So (Confidence: 11)
ce (Confidence: 17)
I (Confidence: 14)
Ta (Confidence: 13)
ra (Confidence: 1)
Ter (Confidence: 33)
Tee (Confidence: 27)
al (Confidence: 21)
Oseye (Confidence: 0)
Ton (Confidence: 28)
eiesinscie (Confidence: 0)
onde. (Confidence: 31)
L (Confidence: 30)
besser (Confidence: 24)
Pervet (Confidence: 0)
w (Confidence: 57)
askin (Confidence: 22)
& (Confidence: 22)
3iab (Confidence: 0)
PONE (Confidence: 36)
DeApaad (Confidence: 0)
5 (Confidence: 49)
iow (Confidence: 6)
oe (Confidence: 13)
eareaince (Confidence: 0)
a (Confidence: 24)
Tt (Confidence: 9)
De (Confidence: 56)
Mui (Confidence: 19)
recelan.g (Confidence: 0)
Dos (Confidence: 0)
eepenceee (Confidence: 0)
eae (Confidence: 0)
Pit (Confidence: 19)
depinibtaine (Confidence: 0)
Dal (Confidence: 0)
Take (Confidence: 27)
Ln (Confidence: 17)
x (Confidence: 49)
50 (Confidence: 15)
Demedany (Confidence: 0)
yah (Confidence: 31)
a (Confidence: 24)
Po (Confidence: 13)
tae (Confidence: 37)
ana (Confidence: 30)
pe (Confidence: 29)
07/19/2024 (Confidence: 28)
3:10PM (Confidence: 67)
CGMT-04: (Confidence: 66)
00% (Confidence: 65)
